Payer Value Propositions in a More Constricted, Cost-controlled Environment
Request access to watch On-Demand. Originally recorded April 20, 2010.
Solid clinical trial data and a payer contract are no longer the benchmarks for commercial success in today's dynamic market. Payers' influence continues to grow. Combine that with the potential changes included in health reform proposals and the increasing demand for comparative effectiveness data, and it's clear that the formula for effective product commercialization has become substantially more complex.
Xcenda's Managed Markets consultants will discuss how manufacturers are revamping their approach to managed care messaging to increase their products' market opportunity. Key points for their presentation include:
- The impact of the changing payer environment
- How to build a payer value proposition throughout the product life cycle
- Communicating value propositions to payers, with a specific focus on FDAMA Section 114
Speakers:
Matt Sarnes, PharmD, Vice President
Laura Happe, PharmD, MPH, Director
Moderator: Stacie Heller, Senior Director of Health Policy Consulting
